SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is under intense scrutiny as investors anticipate Samsung's upcoming preliminary earnings report, which serves as a major bellwether for the memory chip sector and AI-driven demand. While some in the community remain bullish on the long-term supply bottleneck and new automotive partnerships, others are concerned by technical weakness and broader concerns over cyclical volatility.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is seeing intense volatility as investors debate whether the current memory cycle is peaking or merely entering a new phase of long-term AI-driven demand. While some in the community are warning of a bubble and technical overextension, many others are dismissing the price swings as orchestrated shakeouts and capitalizing on the dip in anticipation of strong upcoming earnings.

Roundhill ETF Trust - Roundhill Memory ETF

The Roundhill Memory ETF (DRAM) is experiencing significant volatility driven by market sensitivity to Samsung's earnings guidance, broader semiconductor sector rotation, and anticipation surrounding the upcoming SK Hynix Nasdaq listing. While some investors are concerned about potential supply-demand imbalances, the community remains intensely focused on the structural long-term thesis that AI infrastructure demand will sustain a powerful memory upcycle.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is surging as investors react to a Q2 delivery beat and raised annual production guidance, fueling optimism that the company is effectively scaling production and demand. The stock is currently the focus of intense debate between bullish traders eyeing a potential short squeeze and skeptics who remain wary of the company's capital-intensive path to profitability.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv is currently trending following a notable leadership change, as the company announced Takis Georgakopoulos as the new CEO after Mike Lyons stepped down to lead Truist Financial. While the stock has faced downward pressure and volatility, the community is actively debating whether the current low valuation represents a bargain opportunity due to the company's focus on AI integration and payment processing infrastructure, or if it remains a value trap.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing extreme volatility and a sharp sell-off driven by South Korean regulatory crackdowns on high-leverage single-stock ETFs and concerns regarding institutional rebalancing. The community is actively debating whether this represents a long-term liquidity drain or a tactical buying opportunity, as traders weigh the impact of memory chip supply constraints against the risk of further technical liquidations.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is seeing a significant surge in trading volume and renewed investor interest following its recent inclusion in the Russell 3000 index, which many community members believe is reducing short-seller manipulation. Traders are actively discussing the stock's potential for a broader trend reversal as the company pushes to modernize real estate transactions while navigating technical resistance levels.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares (SOXL) is facing intense volatility as the community debates whether the recent pullback represents a healthy reset for the semiconductor sector or the beginning of a larger correction driven by AI overbuild concerns. Investors are closely monitoring Samsung's strong preliminary earnings and upcoming industry catalysts, while navigating significant bearish sentiment and active debate regarding the sustainability of the AI-driven rally.

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The firm's product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. It is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals is trending following a $10 billion acquisition by Vertex Pharmaceuticals at a substantial premium, a move that validates the company's endocrine-focused pipeline and its lead asset, Palsonify. Investors are actively discussing the deal's structure, the strategic logic behind the acquisition, and celebrating the long-term conviction that led to this buyout.

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks is facing significant volatility as investors debate the impact of broader consumer spending pressures and macroeconomic headwinds on its turnaround strategy. While the community remains divided over its long-term growth potential and current valuation, high-conviction traders are aggressively positioning in long-dated call options, betting on an eventual rebound fueled by cost-cutting initiatives and seasonal demand cycles.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Raphael Pharmaceutical, Inc. is a clinical-stage biotechnology company. It is focused on providing a novel cannabinoid-based research platform for the treatment of inflammatory diseases. The firm’s product candidate, HPC1, is a cannabinoid formulation developed for the treatment of rheumatoid arthritis. The company was founded in May 2007 and is headquartered in Tel Aviv, Israel.

Raphael Pharmaceutical Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

RAPHRaphael Pharmaceutical Inc

Latest RAPH News